David Hoffmeister, last week named new chief financial officer for Invitrogen, will earn a base salary of $425,000 plus an incentive bonus, guaranteed for his first year, and a one-time signing bonus of $375,000, the company said this week in an 8-K filing with the US Securities and Exchange Commission. Hoffmeister will also receive a $224,000 employment bonus payable on or before each of the first three anniversary dates of his employment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.